GlassScriptPhysician profile
Amy Rieder
NPI 1679968002
$6,251.18
in general payments reported to CMS, 2019-2025
35 companies · $1,825 in 2025
The $1,825 reported for 2025 was more than what 92% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $41.97 · 2022: $873 · 2023: $1,638 · 2024: $1,873 · 2025: $1,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,336.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,427.24 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $945.49 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Lilly USA, LLC | $560.92 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $496.39 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $331.43 | 2022-2025 | |
| Abbott Laboratories | $249.95 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3 |
| Astellas Pharma US INC | $240.46 | 2023-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.56 | 2022-2024 | Synjardy, Jardiance, Stiolto Respimat |
| Otsuka America Pharmaceutical, INC. | $180.91 | 2023-2025 | Rexulti |
| Axsome Therapeutics, INC. | $162.45 | 2024-2025 | Auvelity, Symbravo |
| Janssen Pharmaceuticals, INC | $126.61 | 2022-2025 | Xarelto, Spravato |
| Radius Health, INC. | $125.98 | 2025 | Tymlos |
| Exact Sciences Corporation | $123.68 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $120.20 | 2022-2025 | Repatha, Otezla, Krystexxa |
| Glaxosmithkline, LLC. | $111.88 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $91.88 | 2024-2025 | Nexplanon |
| Mylan Specialty L.P. | $81.17 | 2022-2024 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $74.92 | 2022-2025 | |
| Lundbeck LLC | $70.67 | 2024-2025 | Rexulti |
| Merck Sharp & Dohme LLC | $52.00 | 2022-2023 | Belsomra |
| Phathom Pharmaceuticals, INC. | $49.15 | 2024-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $46.18 | 2024 | Eliquis |
| Sumitomo Pharma America, INC. | $44.78 | 2023-2024 | Gemtesa |
| Inspire Medical Systems, INC. | $44.41 | 2023-2024 | Inspire |
| Biohaven Pharmaceutical Holding Company LTD. | $40.83 | 2022 | |
| Dynavax Technologies Corporation | $39.91 | 2024 | Heplisav-B |
| Eisai INC. | $37.30 | 2024-2025 | |
| Corium, LLC | $31.72 | 2022 | |
| Sanofi-Aventis U.S. LLC | $28.79 | 2022 | |
| Ferring Pharmaceuticals INC. | $24.53 | 2025 | Rebyota |
| Ibsa Pharma INC. | $20.80 | 2024 | Licart, Tirosint |
| Novartis Pharmaceuticals Corporation | $19.76 | 2024 | |
| Alnylam Pharmaceuticals INC. | $15.25 | 2024 | Amvuttra |
| Kowa Pharmaceuticals America, INC. | $12.80 | 2022 | |
| Endogastric Solutions, INC | $7.18 | 2023 | Esophyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Rieder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.